# Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia

> **NCT00327054** · PHASE1,PHASE2 · COMPLETED · sponsor: **Aga Khan University** · enrollment: 80 (actual)

## Conditions studied

- Hypercholesterolemia
- Hypertension
- Diabetes Mellitus
- Metabolic Syndrome X

## Interventions

- **DRUG:** Nigella sativa seed

## Key facts

- **NCT ID:** NCT00327054
- **Lead sponsor:** Aga Khan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2015-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00327054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00327054, "Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00327054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*